No Data
No Data
Kunbo Medical-B (02216.HK) spent 0.117 million HKD to repurchase 0.15 million shares on February 27.
According to Gelonghui on February 27, Kunbo Medical-B (02216.HK) announced that on February 27, 2025, it spent 0.117 million HKD to repurchase 0.15 million shares, with a repurchase price of 0.77-0.79 HKD per share.
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
Zhigtong Hong Kong stock repurchase Statistics | February 26.
Hong Kong Stock Repurchase Statistics | February 26
Kunbo Medical-B (02216.HK) spent 0.118 million HKD on February 25 to repurchase 0.15 million shares.
Gelonghui reported on February 25 that Kunbo Medical-B (02216.HK) announced that on February 25, 2025, it spent 0.118 million HKD to repurchase 0.15 million shares, with a repurchase price of HKD 0.78-0.79 per share.
Kunbo Medical-B (02216.HK) repurchased 0.0365 million shares on February 20.
On February 20, Glonghui announced that Kubo Medical-B (02216.HK) spent HKD 0.0277 million to repurchase 0.0365 million shares on February 20, 2025, with a repurchase price of HKD 0.75-0.76 per share.
102768097 : how to do?